3Bardou V J, Arpino G, Elledge R, et al. Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases [ J ]. J Clin Oncol,2003 ;21 (10) : 1973-9.
5Miyoshi Y,Taguchi T,Tamaki Y,et al. Current status of endocrine therapy for breast cancer[J]. Breast cancer,2003 ; 10 ( 2 ) : 105-11.
6Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer[J]. N Engl J Med,2004;351:971-7.
二级参考文献3
1Chlebowski RT,Coln,Winer EP,et al.American.Society of Clincal Oncology assessment of pharmacologic interventions for breast cancer risk reduction includlne tamoxifen, raloxifene,and aromatase inhibition[J].J clin Oncol,2002,20(15):3328.
2GoldhirischA,GlickJH,GelberRD,et al.Meetinghighlight s:International consensus Panel on the Treatment of pimary breast cancer.Seventh international conferenee on adjuvant therapy of primary breast cancer[J].Jclin Oncol,2001,19(18):3817.
8Louwman W J, Vuho J C, Verhoeven R H, et al. Clinical epidemiology of breast cancer in the elderly[J]. Eur J Cancer, 2007, 43 (15) :2242 -2252.
9Tavafian SS, Hasani L, Aghamolaei T, et al. Prediction of breast self-examination in a sample of Iranian women : an application of the Health Belief Model[J]. BMC Womens Health, 2009, 9: 37.
10Gennari R, Curigliano G, Rotmensz N, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients [ J 1. Cancer, 2004, 101 (6) : 1302 - 1310.
